A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease
Haiou Li1, Vandana Sachdev2, Xin Tian3
1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.
British Journal of Haematology
|October 23, 2024
Summary
Allogeneic haematopoietic cell transplantation (HCT) offers a cure for sickle cell disease (SCD). Machine learning identified red cell distribution width and kidney damage as key risk factors for HCT patients.
Area of Science:
- Hematology
- Medical Informatics
- Nephrology
Background:
- Allogeneic haematopoietic cell transplantation (HCT) is a curative option for sickle cell disease (SCD).
- Current risk stratification for HCT in SCD is limited.
- Identifying novel risk factors is crucial for improving patient outcomes.
Purpose of the Study:
- To develop a risk stratification system for patients undergoing HCT for SCD.
- To identify novel clinical and imaging risk factors using a machine learning approach.
Main Methods:
- A machine learning (ML) model was developed.
- The model integrated clinical and imaging variables.
- Risk factors for HCT in SCD patients were identified.
Main Results:
- Red cell distribution width was identified as a significant risk factor.
- Renal organ damage emerged as another critical risk factor.
- The ML algorithm demonstrated potential for risk factor discovery.
Conclusions:
- Red cell distribution width and renal organ damage are important risk factors in HCT for SCD.
- The developed ML-based algorithm can aid in risk stratification.
- This approach may be applicable to similar studies for risk factor discovery.
Related Concept Videos
Bone Marrow Sampling and Transplants
304
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
304
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


